Medical Impact Ventures (MIV) and the American Migraine Foundation (AMF) announced that their collaborative film, Migraine Matters: Bridging the Care Gap, has won a Silver Davey Award for excellence in health advocacy storytelling. The short documentary uses patient stories and clinical evidence to highlight the challenges women face in accessing timely, coordinated migraine care. The project showcases MIV's "medical evidence filmmaking" approach — a blend of data, expert insight, and cinematic narrative designed to drive measurable improvement in health outcomes. The film has been shared widely across AMF and MIV platforms, featured at major headache conferences, and supported through an independent medical education grant from Pfizer.
NEW YORK, Dec. 8, 2025 /PRNewswire-PRWeb/ -- Health Outcomes Agency Medical Impact Ventures (MIV) and the American Migraine Foundation (AMF) today announced that their collaborative film, "Migraine Matters: Bridging the Care Gap," has earned a Davey Award, honoring outstanding achievement in health communication and advocacy storytelling.
Watch the award-winning film: Vimeo Link
The Davey Awards celebrate the world's best small agencies with big ideas. This recognition underscores how MIV and AMF are redefining patient and provider engagement through Hollywood-caliber storytelling fused with scientific rigor — a new genre MIV calls medical evidence filmmaking.
Illuminating the Human Cost of Delayed Care
Produced and directed by MIV in partnership with AMF, "Migraine Matters: Bridging the Care Gap" reveals the unseen barriers women face when navigating fragmented health systems for migraine care. Through intimate patient stories and expert commentary, the film exposes how delayed diagnosis and inadequate coordination impact mental, physical, and financial well-being — and how evidence-based advocacy can change that story.
"Medical evidence filmmaking is the next frontier in healthcare communication," said Matt Wayne, Managing Director of outcomes agency Medical Impact Ventures and co-director of the film. "My goal is to do for healthcare what Coppola and Spielberg did for film — to make it both visionary and deeply human. By merging clinical data with cinematic storytelling, we can humanize statistics, mobilize stakeholders, and ultimately improve outcomes. Medical evidence filmmaking isn't about awareness; it's about transformation. From data to film, from evidence to impact — that's the mission."
"Every medical evidence film we produce is designed to close a real care gap," Wayne added. "When we can increase the number of quality days lived, we know we've achieved what medicine and media together are capable of. Our north star is measurable empathy — using storytelling not just to inform, but to improve lives."
AMF's Mission Brought to Life
"This award validates how powerful partnerships can be when advocacy meets innovation," said Carrie Howell, CEO of the American Migraine Foundation. "Our collaboration with Medical Impact Ventures transformed complex data into a compelling human narrative — one that moves policymakers, payers, and providers alike. Together, we've shown that storytelling informed by evidence can change the trajectory of care for millions living with migraine."
Hosted on AMF's website and amplified through MIV's Outcomes Storytelling microsite, the campaign has reached thousands of patients, clinicians, and policymakers since its debut — bridging awareness with measurable engagement across the migraine community. The film was featured by AMF at the American Headache Society's annual meeting in Minneapolis and will be showcased again at the upcoming conference in Arizona.
Funding for this project was provided through an independent medical education grant from Pfizer Inc. The content was developed independently by the American Migraine Foundation and Medical Impact Ventures.
About the American Migraine Foundation (AMF)
The American Migraine Foundation mobilizes a global community for patient support, advocacy, and research to advance care for people living with migraine and other disabling headache disorders. Founded by the American Headache Society, AMF connects patients, clinicians, and researchers to foster understanding, accelerate solutions, and improve lives.
Learn more at americanmigrainefoundation.org.
For media opportunities, contact Carrie Howell - [email protected].
About Medical Impact Ventures (MIV)
Medical Impact Ventures (MIV) is an AI-Enhanced Outcomes Agency™, cinematic Medical Evidence Film Studio, and venture accelerator redefining how science becomes impact. MIV blends data analytics, behavioral science, and emotionally resonant storytelling to accelerate measurable change among clinicians, patients, and health systems.
By fusing real-world evidence, CME/QI frameworks, and narrative design, MIV partners with pharma, medtech, health systems, payers, and advocacy organizations to deliver measurable improvements in health outcomes.
Beyond client partnerships, MIV also invests in and advises early-stage medical and AI-driven medtech startups that align with its mission to humanize innovation, scale evidence-based care, and expand access through intelligent technology and creative communication.
Integrated Capabilities — AI-Enhanced Outcomes Agency Services Include:
- AI-powered analytics and real-world evidence visualization
- CME/QI design and performance improvement initiatives
- Medical evidence films and patient storytelling platforms
- Behavioral design and health outcomes engineering
- AI Narrative Intelligence™ for adaptive learning and engagement
- Impact measurement and story analytics dashboards
- Bilingual, equity-focused provider and patient education campaigns
- Clinical optimization and workflow consulting
- Real-time outcomes dashboards using EHR and predictive analytics
Trusted by leading pharmaceutical and medical device companies, advocacy organizations, health plans, community hospitals, and academic medical centers, MIV is transforming evidence into measurable action.
Learn more at medicalimpactventures.com or contact
[email protected] | 512-983-2269
Or reach out to our PR agency partner below.
Release Issued by Audience Generation (AG)
Audience Generation (AG) is a next-generation AI-driven marketing communications and PR agency and digital engagement partner to MIV.
To learn how AG can amplify your mission or brand, visit audiencegeneration.com or call 512-708-4678.
Media Contact
Carrie Howell, American Migraine Foundation, 1 317-758-7021, [email protected], americanmigrainefoundation.org
SOURCE American Migraine Foundation
Share this article